Rajendra Apte, MD PhD

Dr. Rajendra S. Apte is the Paul A. Cibis Distinguished Professor at Washington University School of Medicine in St. Louis, Missouri, where he serves as Vice Chair of Innovation and Translation in the Department of Ophthalmology and Visual Sciences, and is a Professor in the Department of Developmental Biology and Medicine. Dr. Apte received his medical degree from the University of Bombay and joined Washington University School of Medicine after obtaining a Ph.D. in Immunology at the University of Texas Southwestern Medical Center in Dallas, Texas, completing a residency at Parkland Hospital, and a retinal vascular and vitreo-retinal surgery fellowship at The Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Apte was recruited to Washington University in 2003 and became a tenured professor at the School of Medicine in less than ten years. Dr. Apte is a vitreoretinal surgeon and clinician scientist. His basic research is focused on inflammation, aging, neurodegeneration and angiogenesis. His clinical research spans the translational spectrum from drug discovery and development to clinical trials. Dr. Apte has published extensively in basic and clinical peer reviewed journals and has participated as a principal investigator in numerous clinical trials. He was appointed in 2020 to be a Permanent Member of the National Eye Institute Board of Scientific Counselors. Dr. Apte has won numerous awards, honors, and educational scholarships. Some recent highlights include: 2022 UT Southwestern Medical Center Distinguished Alumnus, 2018 European Vision and Eye Research Certificate of Honour and Keynote Lecture; 2017 J. Wayne Streilein Distinguished Alumnus Award Lecture in Immunology; 2017 Macula Society W. Richard Green Award; 2017 Glenn Award for Research in Biological Mechanisms of Aging; 2016 Research to Prevent Blindness Nelson Trust Award; 2014 Research to Prevent Blindness Sybil B. Harrington Physician-Scientist Award for Age-Related Macular Degeneration; 2014 ASRS Presidents’ Award; 2013/2014 Carl Camras Translational Research Award, the Macula Society Young Investigator Award in 2013; Julie Martin Mid-Career Award in Aging Research from AFAR in 2012; the Macula Society Retina Research Foundation Cox Research Award in 2010; the American Retina Foundation Research Award in 2008; and the Research to Prevent Blindness Career Development Award in 2004. These awards accompany his 145+ peer-reviewed publications. His entrepreneurial activities include starting four life sciences companies and licensing several technologies, many of which are in human clinical trials. His research has been published in several high impact journals including New England Journal of Medicine, Nature, Cell, Cell Metabolism, the JCI, Nature Communications, PLoS Medicine, PNAS, JAMA Ophthalmology, among others. Additionally, Dr. Apte has professional associations with the American Society for Clinical Investigation, American Academy of Ophthalmology, American Society of Retina Specialists, Association for Research in Visual Ophthalmology, Club Jules Gonin, the Macula Society, and the Retina Society. |
Financial relationships
-
Attribution:SelfType of financial relationship:StockIneligible company:EdenRoc SciencesTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
-
Attribution:SelfType of financial relationship:Stock OptionsIneligible company:Mobius ScientificTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
-
Attribution:SelfType of financial relationship:Stock OptionsIneligible company:QBioMedTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:RocheTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:RibomicTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
-
Attribution:SelfType of financial relationship:Financial SupportIneligible company:Casma TherapeuticsTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
-
Attribution:SelfType of financial relationship:StockIneligible company:Metro InternationalTopic:PharmaDate added:05/19/2022Date updated:05/19/2022
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward